Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization (CF) (2016 - 2025)

Xtant Medical Holdings has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $1.5 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 30.66% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 16.1% year-over-year, with the annual reading at $3.6 million for FY2025, 14.77% down from the prior year.
  • Depreciation & Amortization (CF) was $1.5 million for Q4 2025 at Xtant Medical Holdings, up from $1.2 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.5 million in Q4 2025 and troughed at $281000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $843000.0 (2023), against an average of $746300.0.
  • Year-over-year, Depreciation & Amortization (CF) plummeted 45.26% in 2021 and then surged 216.82% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $291000.0 in 2021, then grew by 10.31% to $321000.0 in 2022, then surged by 216.82% to $1.0 million in 2023, then grew by 12.88% to $1.1 million in 2024, then soared by 30.66% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Depreciation & Amortization (CF) are $1.5 million (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025).